Licht T - Search Results

1

Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.

Schlemmer M, Wendtner CM, Falk M, Abdel-Rahman S, Licht T, Baumert J, Straka C, Hentrich M, Salat C, Hiddemann W, Issels RD. Schlemmer M, et al. Among authors: licht t. Oncology. 2006;71(1-2):32-9. doi: 10.1159/000100447. Epub 2007 Mar 5. Oncology. 2006. PMID: 17344669 Clinical Trial.

2

Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: analysis of remission induction and stem cell mobilization.

Menzel H, Müller A, Von Schilling C, Licht T, Peschel C, Keller U. Menzel H, et al. Among authors: licht t. Leuk Lymphoma. 2008 Jul;49(7):1337-44. doi: 10.1080/10428190802094229. Leuk Lymphoma. 2008. PMID: 18604723 Clinical Trial.

3

Gene therapy for sarcoma.

Fruehauf S, Veldwijk MR, Berlinghoff S, Basara N, Baum C, Flasshove M, Hegewisch-Becker S, Kröger N, Licht T, Moritz T, Hengge UR, Zeller WJ, Laufs S. Fruehauf S, et al. Among authors: licht t. Cells Tissues Organs. 2002;172(2):133-44. doi: 10.1159/000065614. Cells Tissues Organs. 2002. PMID: 12426490 Review.

4

T-cell lymphoproliferative disorder potentially induced by imatinib in a patient with GIST.

Verbeek M, Fend F, Licht T, Büschenfelde CM, Stollfuss J, Peschel C, Duyster J. Verbeek M, et al. Among authors: licht t. Nat Rev Clin Oncol. 2010 Feb;7(2):116-9. doi: 10.1038/nrclinonc.2009.218. Nat Rev Clin Oncol. 2010. PMID: 20118980

5

Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review.

Nieder C, Licht T, Andratschke N, Peschel C, Molls M. Nieder C, et al. Among authors: licht t. Cancer Treat Rev. 2003 Feb;29(1):11-9. doi: 10.1016/s0305-7372(02)00094-4. Cancer Treat Rev. 2003. PMID: 12633576 Review.

6

Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study.

Joka M, Boeck S, Zech CJ, Seufferlein T, Wichert Gv, Licht T, Krause A, Jauch KW, Heinemann V, Bruns CJ. Joka M, et al. Among authors: licht t. Anticancer Drugs. 2014 Oct;25(9):1095-101. doi: 10.1097/CAD.0000000000000146. Anticancer Drugs. 2014. PMID: 25029236 Clinical Trial.

7

Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status.

Hoellein A, Decker T, Bogner C, Oelsner M, Hauswald S, Peschel C, Keller U, Licht T. Hoellein A, et al. Among authors: licht t. J Cancer Res Clin Oncol. 2010 Mar;136(3):403-10. doi: 10.1007/s00432-009-0670-9. Epub 2009 Sep 1. J Cancer Res Clin Oncol. 2010. PMID: 19727816

8

Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance.

Licht T, Bross KJ, Fiebig HH, Schötta K, Berger DP, Dreher C, Löhr GW, Herrmann F. Licht T, et al. J Cancer Res Clin Oncol. 1992;118(2):116-22. doi: 10.1007/BF01187499. J Cancer Res Clin Oncol. 1992. PMID: 1735731

9

The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders.

Licht T, Pastan I, Gottesman MM, Herrmann F. Licht T, et al. Ann Hematol. 1996 Apr;72(4):184-93. doi: 10.1007/s002770050159. Ann Hematol. 1996. PMID: 8624371 Review.

10

Restoration of transgene expression in hematopoietic cells with drug-selectable marker genes.

Licht T, Peschel C. Licht T, et al. Curr Gene Ther. 2002 May;2(2):227-34. doi: 10.2174/1566523024605636. Curr Gene Ther. 2002. PMID: 12109218 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters